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A protein with an apparent mass of 36 kDa was 
purified from Drosophila melanogaster embryos using 
a protocol developed for the purification of proliferat- 
ing cell nuclear antigen (PCNA) from human 293 cells. 
The Drosophila protein comigrated with human PCNA 
on one-dimensional sodium dodecyl sulfate-polyacryl- 
amide gels and cross-reacted with monoclonal anti- 
rabbit PCNA antibodies. NHz-terminal amino acid se- 
quence analysis revealed that the putative Drosophila 
PCNA was highly homologous to human PCNA. Of the 
first 22 amino acids, 16 were identical, and 4 of the 
remaining 6 were changed conservatively. Results of 
total amino acid analysis were also consistent with a 
high degree of similarity between Drosophila PCNA 
and human PCNA. Functional analysis using the re- 
constituted simian virus 40 in vitro DNA replication 
system demonstrated that Drosophila PCNA could sub- 
stitute, albeit with reduced efficiency, for human 
PCNA in stimulating simian virus 40 DNA synthesis. 
Affinity-purified anti-Drosophila PCNA antibodies 
cross-reacted with human PCNA and were able to rec- 
ognize specifically Drosophila PCNA both on crude 
homogenate immunoblots and by indirect immunoflu- 
orescence analysis of proliferating cells in larval tis- 
sues in situ. These antibodies thus promise to be useful 
probes for the study of cell proliferation in this rapidly 
developing organism. 
Proliferating cell nuclear antigen (PCNA),’ as its name 
implies, is found in high concentrations only in actively 
dividing cells (for recent reviews, see Celis et al., 1987; Tan, 
1989). Originally recognized as an autoimmune antigen in a 
subset of human patients with systemic lupus erythematosus 
(Miyachi et al., 1978), it has now been identified as a highly 
conserved protein in a number of widely divergent species 
(see e.g. Bravo and Celis, 1980; Bravo et al., 1981; Mathews 
et al., 1984; Bauer and Burgers, 1988; Olins et al., 1989). 
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Interest in PCNA was sparked recently by recognition of 
its essential role in SV40 DNA replication in uitro (Prelich et 
al., 1987a; Prelich and Stillman, 1988). It was proposed that 
PCNA acts as an auxiliary factor for DNA polymerase 6, 
facilitating processive leading strand DNA synthesis by this 
enzyme (Tan et al., 1986; Bravo et al., 1987; Prelich et al., 
1987b). A role for PCNA in host chromosomal replication has 
also been suggested based both on results of in vivo antibody 
microinjection studies (Zuber et al., 1989) and in situ immu- 
nocytochemistry (see e.g. Celis and Celis, 1985; Bravo and 
Macdonald-Bravo, 1985, 1987; Olins et al., 1989). However, 
this role is not yet proven. 
We expected that Drosophila melarwgaster would possess a 
protein homologous to mammalian PCNA. Unlike any ver- 
tebrate, Drosophila is a higher eukaryote suited to systematic 
genetic manipulation. If Drosophila PCNA could be identified, 
there would be the potential to demonstrate directly by genetic 
means the postulated role of PCNA in eukaryotic chromo- 
somal replication. In addition, PCNA might represent an ideal 
marker to correlate cell proliferation with differentiation in 
this rapidly developing organism. 
In this paper, we report the identification and purification 
of Drosophila PCNA. Analyses of NH2-terminal protein se- 
quence and total amino acid composition suggest that it is 
structurally homologous to mammalian PCNA. Functional 
studies indicate that Drosophila PCNA can substitute, albeit 
with reduced efficiency, for human PCNA in a reconstituted 
SV40 DNA replication system in vitro. Polyclonal antibodies 
raised against Drosophila PCNA promise to be useful both in 
developmental studies and for immunocytochemistry. 
EXPERIMENTAL PROCEDURES 
Materials-The sources of most of the materials were as described 
previously (Smith et al., 1987). [cx-~*P]~ATP was from Du Pont-New 
England Nuclear. 
Antibodies-Affinity-purified goat anti-rabbit IgG and goat anti- 
mouse IaG were from CaDnel Laboratories (Cochranville, PA). Rho- 
damine-conjugated affinity-purified donkey anti-rabbit IgG was from 
Jackson ImmunoResearch (West Grove, PA). Rabbit anti-Drosophila 
PCNA antibodies and anti-Drosophila lamin antibodies were affinity 
purified according to Fisher and Smith (1988). Monoclonal anti- 
rabbit PCNA antibodies 19A2 and 19F4 were as described (Ogata et 
al., 1987). Rabbit anti-DNA topoisomerase II antiserum was as spec- 
ified previously (Berrios et al., 1985) and was the generous gift of Dr. 
Neil Osheroff (Vanderbilt University, Nashville, TN). 
Purification of Drosoahila PCNA-D. melanogaster (Oregon R, P2 
strain)‘were grdwn in mass culture according to Allis et al. (1977). 
PCNA was purified from 30-50 ml of 0-12-h-old embryos essentially 
according to Prelich et al. (1987a). Frozen embryos were thawed and 
Dounce homogenized in a buffer containing 50 mM Tris-HCl, pH 8, 
0.5 mM marmesium acetate, 0.05 mM EDTA. 5 mM KCl, 0.35 M 
sucrose, 1 &M dithiothreitoi, 1 mM phenylm&hylsulfonyl fluoride, 
and 2 pg/ml leupeptin. The homogenate was filtered through 120~pm 
nylon mesh and then spun first at 10,000 X g and then at 100,000 X 
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8. The 100,000 X g (postribosomal) supernatant was loaded onto a 
phosphocehulose column (600 ml) that had been preequilibrated in 
buffer A (50 mM Tris-HCl. oH 8. 1 mM EDTA. 0.01% Nonidet P-40. 
10% glycerol, 1 mM dithiothreitoi, and 0.1 mM phenylmethylsulfonyi 
fluoride) containing 175 mM NaCI. Protein concentration was deter- 
mined by the Bio-Rad protein assay. The protein that flowed through 
the column (nhosnhocellulose fraction) was loaded onto a DEAE- 
cellulose column (600 ml) preequilibrated in buffer A with 175 mM 
NaCl. Proteins were eluted with 1 M NaCl in buffer A. The protein 
neak (DEAE-cellulose fraction) was adiusted to 1 M (NH,)SO, and ._ 
applied to a phenyl-Sepharose column (45 ml) preequilibrated in 
buffer A containing 1 M (NH,)$O,. Proteins were eluted with a linear 
gradient of decreasing ionic strength formed by buffer A containing 
0.5 M (NHJ)$O, to buffer A alone. PCNA was detected by immuno- 
blotting using monoclonal anti-rabbit PCNA antibodies 19A2 and 
19F4. The pooled peak of PCNA was dialyzed against buffer A 
containing 25 mM NaCl and 20% sucrose. It was then loaded onto a 
QAE-Sepharose column (11 ml) preequilibrated in buffer A with 0.2 
M NaCI: PCNA was eluted with a linear gradient of 0.2-0.6 M NaCl 
in buffer A. Pooled fractions were dialyzed against 25 mM NaCl and 
20% sucrose in buffer A and stored at -70 “C. 
Production of Anti-Drosophila PCNA Antiserum-Antibodies to 
Drosophila PCNA were raised in a female New Zealand White rabbit 
essentially as described by Fisher et al. (1982). The QAE-Sepharose 
fraction prepared from 35 ml of 0-12-h-old embryos was subjected to 
electrophoresis on a preparative SDS-polyacrylamide (10%) gel. The 
gel was stained with Coomassie Blue, destained, and dried onto 
Whatman 3MM paper. The band of PCNA was excised, rehydrated 
in water, and then homogenized in water with a motor-driven Teflon 
pestle. PCNA was eluted by shaking the homogenized gel in 100 mM 
NaPHPO.,, 0.1% SDS. - - 
Amino Acid Analvsis and Seouencins of Drosovhila PCNA-PCNA - , 
was gel purified and extracted from the sliced gel as described above 
for preparation of antigen, trichloroacetic acid precipitated, and dis- 
solved in 0.1 M ammonium hydroxide, 0.1% SDS. Amino-terminal 
protein sequence analysis was performed using an Applied Biosystems 
470A sequenator equipped for on-line detection of phenylthiohydan- 
toin derivatives as described (Lees-Miller and Anderson, 1989). 
Amino acid composition was determined using a Hewlett-Packard 
Aminoquant system. Before analysis, the protein was hydrolyzed for 
24 h at 110 “C in 6 N HCl. 
SDS-Polyacrylamide Gel Electrophoresis (SDS-PAGE) and Immu- 
noblot Analysis-SDS-PAGE was essentially according to Laemmli 
(1970) as modified (Fisher et al., 1982). Proteins were transferred 
either passively or electrophoretically from SDS-polyacrylamide gels 
onto nitrocellulose. Immunoblots were probed with specific antibodies 
(Blake et al., 1984; Smith and Fisher, 1984). Calf alkaline phosphatase 
was glutaraldehyde conjugated to affinity-purified goat anti-IgG an- 
tibodies according to Avrameas (1969); calorimetric detection of 
alkaline phosphatase activity on blots was according to McGadey 
(1970). 
Indirect Immunofluorescence-Indirect immunofluorescence was 
performed on Drosophila third instar larval tissues exactly as de- 
scribed previously (Fisher et al., 1982). Detection of specific antibody 
staining was with affinity-purified rhodamine-conjugated donkey 
anti-rabbit IgG diluted at 1:50. Additional details are included in the 
figure legends. 
In Vitro Replication of Plasmid DNA Containing the SV40 Origin 
of Replication-Standard replication reactions (25 ~1) were performed 
essentially as described by Tsurimoto et al. (1989) and contained 
plasmid pSVOl1 as template DNA (Prelich and Stillman, 1988). The 
reconstituted replication system contained purified SV40 T antigen 
(Simanis and Lane, 1985),~RF-A (Fairman and Stillman, 1988; W-old 
and Kellv. 1988). RF-C (Tsurimoto and Stillman. 1989a). human 
PCNA produced from an Escherzchia coli expression vector’ or Dro- 
sophzla PCNA (described herein), DNA topoisomerases I and II, and 
the nonpurified fraction IIA (Tsurimoto et al., 1989). Reactions were 
for 1 h at 37 “C, and reaction products were analyzed by trichloroa- 
cetic acid precipitation or by electrophoresis on an 0.8% agarose gel 
as described in the legend to Fig. 4. 
RESULTS 
Purification of a Putative PCNA Homolog from Drosophila 
Embryo Extracts-Monoclonal antibodies 19A2 and 19F4, 
’ K. Fien and B. Stillman, unpublished observations. 
A B 
a b C d e f9h a bed e f 9 h 
Frc. 1. Purification of Drosophila PCNA. A, SDS-PAGE 
(10%) of fractions generated during purification of Drosophila PCNA. 
Purification and SDS-PAGE were performed as described under 
“Experimental Procedures.” The gel was stained with Coomassie 
Blue. One unit is defined as the amount of material derived from 1 
~1 of embryos (-40-50 organisms). Lane a, 0.5 unit of filtered crude 
homogenate; lane b, 0.5 unit of 10,000 x g supernatant; lane c, 0.5 
unit of 100,000 X g supernatant; lane d, 0.5 unit of phosphocellulose 
flow-through; lane e, 3 units of DEAE-cellulose eluate; lanef, 25 units 
of phenyl-Sepharose eluate; laneg, 60 units of QAE-Sepharose eluate; 
lane h. 1 fig of purified human PCNA. B, proteins from a gel run in 
parallel to-A were electrophoretically transferred to nitrocellulose. 
The resultine blot was orobed with monoclonal anti-rabbit PCNA 
antibodies 19A2 ascites fiuid at 1:2000 dilution and 19F4 tissue culture 
supernatant at 1:30 dilution. Standard molecular mass markers are 
indicated by arrows to the right of each panel and are (in kDa), from 
top to bottom: 92.5, 69, 46, and 30. 
raised against rabbit PCNA, recognize this protein from both 
rabbits and humans (Ogata et al., 1987). We considered it 
possible that these antibodies would also recognize a putative 
Drosophila PCNA homolog. In preliminary experiments, im- 
munoblot analyses performed with these antibodies on Dro- 
sophila embryo extracts revealed a faint band of immunoreac- 
tivity which was apparently specific and migrated at about 
the same position as human PCNA (not shown). However, 
also seen were several bands of equal or greater intensity (see 
Fig. lB, lane a) which were apparently nonspecific. We there- 
fore set about to purify this minor immunoreactive Drosophila 
protein using a protocol similar to that reported for purifica- 
tion of human PCNA by Prelich et al. (1987a). The putative 
Drosophila PCNA homolog was detected during purification 
by immunoblot analysis using monoclonal antibodies 19A2 
and 19F4. 
Fig. lA shows a Coomassie Blue-stained SDS-polyacryl- 
amide gel; Fig. 1B shows an immunoblot of an identical gel, 
run in parallel to the one shown in Fig. lA, and probed with 
a mixture of monoclonal anti-rabbit PCNA antibodies 19A2 
and 19F4. Although there appear to be many immunoreactive 
polypeptides in the crude embryo homogenate (Fig. lB, lane 
a), probing parallel blots with only the secondary antibody 
(not shown) demonstrated that all those seen in Fig. lB, lane 
a, were apparently nonspecific. Specific reactivity of an ap- 
propriately sized Drosophila polypeptide with monoclonal 
anti-rabbit PCNA antibodies was first evident after DEAE- 
cellulose chromatography (Fig. lB, lane e) although this spe- 
cies could be seen in earlier fractions if more material was 
loaded on the gel. 
Two major bands of Coomassie Blue-stainable protein were 
seen in the QAE-Sepharose eluate (Fig. lA, lane g). The lower 
of the two was exactly coincident in SDS-PAGE mobility 
with the major band of specific reactivity seen on a parallel 
immunoblot probed with monoclonal antibodies 19A2 and 
19F4 (Fig. lB, lane g). In this analysis, this band migrated 
slightly slower than a human PCNA standard loaded and run 
on the same gel (Fig. 1, A and B, lanes h).” A second band of 
” Before electrophoresis, samples run on gels shown in Figs. 1, 3, 
and 5 were treated with iodoacetamide. Samples run on the gel shown 
in Fig. 4A were not. This may account for the slight difference in 
relative mobilities between Drosophila PCNA and human PCNA seen 
under the two different conditions. 
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Drosophila Proliferating Cell Nuclear Antigen 
immunoreactivity seen at about 50 kDa in Fig. lB, lane g, is 
apparently nonspecific (see Fig. 30). 
Biochemical and Immunochemical Homologies between Dro- 
sophila PCNA and Human PCNA-To establish definitively 
the identity of the major immunoreactive Coomassie Blue- 
stainable protein band in Fig. lA, lane g, as a Drosophila 
PCNA homolog, approximately 200 rg of this polypeptide was 
purified from the QAE-Sepharose eluate by preparative SDS- 
PAGE; 26 pg was subjected to NHg-terminal sequence analy- 
sis, an identical amount was used for determination of total 
amino acid composition, and the remainder was used to im- 
munize a rabbit for antibody production. 
The results of NHL-terminal sequence analysis are pre- 
sented in Fig. 2. A single sequence was obtained in the first 
10 cycles of Edman degradation, and a major sequence con- 
tinued and could be read unambiguously for 22 cycles. This 
sequence was identical to that of human PCNA at 16 of the 
22 residues (Fig. 2). The yield of methionine in the 1st residue 
was 275 pmol, suggesting that in Drosophila the initiating 
methionine residue is not removed from PCNA. Careful in- 
spection of the sequence data (not shown) revealed distinct 
minor sequences that were closely related to the main se- 
quence beginning at cycles 11, 13, 17, and 19. The minor 
sequences appeared to result from amino acid insertion, dele- 
tion, or substitutions and suggest that PCNA may be encoded 
by several closely related genes. It is also possible that minor 
sequences resulted from sequence-specific partial failure of 
the Edman chemistry causing partial asynchrony of the se- 
quence at certain positions. 
The amino acid composition of SDS-PAGE-purified Dro- 
sophila PCNA is shown in Table I. In comparison with the 
amino acid composition of human PCNA deduced from a 
cDNA clone (Almendral et al., 1987), Drosophila PCNA is 
quite similar. 
The reactivity of antiserum raised against SDS-PAGE- 
purified Drosophila PCNA was compared by immunoblot 
analysis with that of monoclonal anti-rabbit PCNA antibodies 
19A2 and 19F4. Both human PCNA and the QAE-Sepharose 
eluate enriched for Drosophila PCNA were subjected to elec- 
trophoresis on four identical SDS-polyacrylamide gel seg- 
ments. One segment (Fig. 3A) was stained with Coomassie 
Blue while proteins from the other three were blot-transferred 
to nitrocellulose. The blot shown in Fig. 3B was probed with 
anti-Drosophila PCNA antiserum; the blot shown in Fig. 3C 
was probed with a mixture of monoclonal anti-rabbit PCNA 
antibodies 19A2 and 19F4; the blot shown in Fig. 30 was 
probed with secondary antibodies only. 
Clearly, the anti-Drosophila PCNA antiserum was highly 
reactive with the antigen against which it was raised (Fig. 3B, 
lanes b-d). Limited cross-reactivity with human PCNA was 
also observed (see Fig. 3B, lane e). Conversely, monoclonal 
human 
Drosophila 
FI(;. 2. NH2-terminal sequence comparison between human 
PCNA and the putative Drosophila homolog. Identical amino 
acids are connected by dashed lines and are boxed. Amino acids 
changed conservatively are connected by dashed lines only. Amino 
acid yields over the first 10 cycles were as follows: cycle 1, 275 pmol 
of methionine; cycle 2, 242 pmol of phenylalanine; cycle 3, 124 pmol 
of glutamic acid; cycle 4, 234 pmol of alanine; cycle 5, 37 pmol of 
arginine; cycle 6, 277 pmol of leucine; cycle 7, 136 pmol of glycine; 
cycle 8, 132 pmol of glutamine; cycle 9, 189 pmol of alanine; cycle 10, 
44 pmol of threonine. 
TABLE I 
Amino acid comDosition of DrosoDhila PCNA 
Amino 
acid 
LYS 
His 
Arg 
Asp + Asn 
Thr 
Ser 
Glu + Gln 
Pro 
GUY 
Ala 
Val 
Met 
nIXlo 
7.38 
1.43 
4.67 
15.46 
7.43 
7.72 
15.98 
3.09 
6.21 
11.43 
8.75 
5.60 
Calculated 
residues 
15.8 
3.1 
10.0 
33.1 
15.9 
16.4 
34.1 
6.6 
13.3 
24.4 
18.7 
12.0 
Human PCNAb 
16 
3 
8 
30 
12 
25 
31 
14 
19 
21 
10 
Ile 7.26 15.5 14 
Leu 11.64 24.9 29 
% 2.72 5.8 7 
Phe 5.56 11.9 8 
Trp 1 
Cys’ 6 - 
Total 261 
” Calculated no. of residues assumes molecular weight = 29,261. 
b Values are derived from the published sequence of human PCNA 
deduced from a cDNA clone (Afmendral et al., 1987). 
’ Before SDS-PAGE. the QAE-Senharose fraction was reduced and 
treated with iodoacetamide to alkyiate -SH groups. Carboxymeth- 
ylcysteine was identified but not quantitated in the subsequent amino 
acid analysis. 
A B c D 
a bcde rbcde abc de a bcde 
FIG. 3. Immunochemical homology between Drosophila 
PCNA and human PCNA. Drosophila QAE-Sepharose fraction and 
purified human PCNA were subjected to electrophoresis on SDS- 
polyacrylamide (10%) gels and proteins transferred electrophoreti- 
tally to nitrocellulose. QAE-Sepharose fraction was loaded in lane b, 
24 units; lane c, 48 units; and lane d, 96 units. Human PCNA was 
loaded in lane a, 0.25 pg, and lane e, 0.75 Fg. A, the gel was stained 
with Coomassie Blue after electrophoresis. Three immunoblots (B- 
D) were prepared from gels run in parallel. The blot shown in B was 
probed with anti-Drosophila PCNA antiserum at 1:lOOO dilution. The 
blot shown in C was probed with monoclonal anti-rabbit PCNA 
antibodies 19A2 ascites fluid, diluted at 1:2000 and 19F4 tissue culture 
supernatant, diluted at 1:30. The blot shown in D was probed with 
calf alkaline phosphatase-conjugated goat anti-mouse and goat anti- 
rabbit IgG antibodies only. Arrows to the left of panel A designate 
marker positions as in Fig. 1. 
anti-rabbit PCNA antibodies were highly cross-reactive with 
human PCNA (Fig. 3C, lanes a and e) and showed only limited 
cross-reactivity with Drosophila PCNA (Fig. 3C, Lanes b-d). 
Functional Homology between Drosophila PCNA and Hu- 
man PCNA-In light of the high degree of conservation 
between Drosophila PCNA and human PCNA, we thought it 
possible that Drosophila PCNA might substitute for human 
PCNA in the reconstituted SV40 in vitro DNA replication 
system. Drosophila PCNA was purified for this experiment 
under conditions to maximize purity. This entailed taking 
very narrow pools of PCNA elution peaks in each of the last 
two column chromatography steps. 
The purified PCNA fractions from both Drosophila and 
humans were compared by SDS-PAGE (Fig. 4A). In this 
analysis, the two proteins migrated nearly identically.3 The 
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FIG. 4. Functional homology be- 
tween Drosophila PCNA and hu- 
man PCNA. A, SDS-PAGE analysis of 
purified I~rosoph~la PCNA and human 
I’CNA. Following electrophoresis, the 
gel was stained with Coomassie Blue to 
show the amounts of ZIrosophlla PCNA 
and human PCNA added to each reac- 
tlon. H. stimulation of In vitro SV40 
DNA replication 1)~ IIrosoph& and hu- 
man PCNA. Reactlons, 25 ~1 each, con- 
tained 150 ng of pSVOl1 plasmid DNA, 
0.3 pg of SV40 T antigen, 200 ng of DNA 
topoisomerase I. 90 ng of DNA topo- 
isomerase II. 650 ng of RF-A, 100 ng of 
RF-C. 20 uz of fraction IIA. and increas- 
ing amoun;s of PCNA as indicated. Re- 
actions were incubated at 37 “C for 1 h. 
A portion of each reaction was termi- 
nated by the addition of EDTA to 10 
mM. precipitated by 8% trichloroacetic 
acid containing 1% sodium pyrophos- 
phate. and flltered through glass fiber 
i‘ilters. Amounts of incorporated [“‘PI 
dAMP were determined bv liauid scin- - . 
tlllation counting. C, the other portions 
of replication products were analyzed by 
agarose gel electrophoresis. Positions of 
form I and II products are indicated on 
the kft 
A 
Drosophila HWlWn 
II 
PCNAQqL9) 0.2 0.4 0.8 0.2 0.4 0.8 M 
- 205 
- 116 
- - 68 
- /- 45 
PCNA --3 -.- - -- 
- - 29 
. / - 20 
-- 12 
B 
60- Human 
2 IO- 
I 
0 01 02 03 
PCNA(ug) 
Human Drosophllo M 
lb -03 
-01 
effects of adding either to an otherwise complete SV40 DNA 
replication reaction were determined both quantitatively and 
qualitatively. From the quantitative analysis (Fig. 4B), it can 
be seen that both proteins stimulated the rate of dAMP 
incorporation with similar kinetics. However, the maximal 
human PCNA-stimulated rate was about twice that observed 
for Drosophila PCNA. From the qualitative analysis (Fig. 4C), 
it was clear that Drosophila PCNA acted in a manner that 
was mechanistically homologous to human PCNA, i.e. it fa- 
cilitated the synthesis of full-length SV40 DNA whereas in 
its absence, short non-template-bound products were ob- 
served which are similar to those described previously (Prelich 
and Stillman, 1988). These short products are variably lost 
during drying of the agarose gel prior to autoradiography, 
perhaps accounting for the apparent discrepancy in saturation 
kinetics between the dAMP incorporation assay (Fig. 4B) and 
product analysis on agarose gels (Fig. 4C). The product analy- 
sis rather than measurement of acid insoluble radioactivity 
more accurately reflects Drosophila PCNA function. 
Steady-state Levels of Drosophila PCNA during Develop- 
ment-Polyclonal anti-Drosophila PCNA antibodies were 
used for immunoblot analyses to evaluate the relative steady- 
state levels of PCNA through development. During embryo- 
genesis, PCNA levels were highest early when rates of DNA 
replication were maximal and decreased markedly as devel- 
opment proceeded (Fig. 5A). In contrast, steady-state levels 
of two other nuclear proteins, DNA topoisomerase II (Fig. 
5R) and lamin (Fig. 5C), seemed to increase throughout the 
same period. Also evident on the blot probed with anti-PCNA 
antiserum in Fig. 5A is an immunoreactive polypeptide of 
approximately 50 kDa which seems to be regulated in a 
manner similar to PCNA during embryogenesis. Reactivity of 
the anti-Drosophila PCNA antiserum with this 50-kDa poly- 
peptide in crude extracts is apparently specific (compare Fig. 
5A with Fig. 5B; also see below). 
Results of immunoblot analysis of later developmental 
stages with anti-Drosophila PCNA antibodies are presented 
in Fig. 50. Only the region of the blot containing PCNA is 
shown. Most notable in this experiment were the increased 
levels of PCNA seen in adult females as opposed to males 
(compare Fig. 50, lanes i and j). This finding is consistent 
with the notion that the elevated levels of PCNA early in 
embryogenesis represent maternal stores of this protein ac- 
cumulated during oogenesis. 
In Situ Immunolocalization of Drosophila PCNA-Devel- 
opmental immunoblot studies with anti-Drosophila PCNA 
antibodies were complemented by indirect immunofluores- 
cence analyses performed on selected tissues dissected from 
Drosophila third instar larvae. For these experiments, anti- 
PCNA antibodies were affinity purified on a PCNA-Sepha- 
rose column (see “Experimental Procedures”). Although affin- 
ity purification reduced the level of apparently nonspecific 
background seen both on immunoblots and by immunofluo- 
rescence, blot immunoreactivity with the 50-kDa species seen 
with unfractionated serum (Fig. 5A) was undiminished with 
affinity-purified anti-PCNA IgG (not shown). Therefore, in 
considering immunofluorescence data, although we think it 
unlikely, we cannot exclude the possibility that patterns ob- 
served reflect the distribution of this 50-kDa protein in ad- 
dition to or instead of those of PCNA. 
The third instar larval neural ganglion is a heterogeneous 
tissue made up of many different cell types. Most are small 
cells that are apparently nondividing, but some of the cells 
are much larger, and mitotic figures are easily found among 
this group. The distribution of PCNA in third instar larval 
neural ganglion tissue was evaluated by indirect immunoflu- 
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FIN:. 5. Immunoblot analysis of Drosophila PCNA levels 
through development. Electrophoresis was on SDS-polyacrylamide 
(7%) gels. Proteins were transferred passively to nitrocellulose, and 
blots were processed and probed as described under “Experimental 
Procedures.” A-C, total extracts from embryos of various ages were 
prepared by Dounce homogenization of dechorionated embryos di- 
rectly into boiling SDS; 500 pg of protein from each extract was 
loaded onto each of three parallel gel segments; lanes a, 0-s-h-old 
embryos; lanes b, 6-g-h-old embryos; lanes c, 12-15.h-old embryos. 
The blot inpanelA was probed with anti-Drosophila PCNA antiserum 
diluted 1:1000; similar results were obtained with affinity-purified 
anti-l1rosopMa PCNA IgG (not shown). The blot in panel R was 
probed with anti-DrosopMa topoisomerase II antiserum diluted 
1:lOOO. The blot in panel C was probed with affinity-purified anti- 
Z1rosophila lamin IgG at a final concentration of 0.5 pg/ml. IL, extracts 
were prepared and processed as in A-C but from Drosophla at all 
developmental stages; lane o, 0-s-h-old embryos; lane b, 6-g-h-old 
embryos; lane c, 12-l&h-old embryos: lane d, 19-22-h-old embryos; 
lane e, first instar larvae; lane f, second instar larvae; lane g, third 
instar larvae; lane h, pupae; Lane 1, adult males; lane J, adult females. 
The blot was probed with anti-DrosopMa PCNA antiserum as in A. 
Only a portion of the blot is shown. Arrows to the left ofpanels A and 
11 indicate the mobility of a purified L)rosophk~ PCNA standard run 
in parallel to the samples used for immunoblot analysis. Arrows to 
the right of pnnel C indicate the mobility of Drosophla DNA topoi- 
somerase II (upper nrrou,), 166 kDa; and Drosophda nuclear lamins 
(/ou,er doublet of arrows) DmL (76 kDa) and Dm, (74 kDa). 
orescence microscopy. The results of this analysis are shown 
in Fig. 6. Fig. 6, a, d, and 6 are phase-contrast micrographs; 
Fig. 6, b, e, and h are immunofluorescence micrographs; Fig. 
6, c, f, and i are fluorescence micrographs of the same cells 
stained with the DNA-specific dye DAPI. The specimens in 
panels a-c and d-f were probed with affinity-purified anti- 
PCNA antibodies; the specimen in panels g-i was probed with 
preimmune rabbit IgG. 
From the specimens in Fig. 6, u-c and d-f, it can be seen 
that most or all of the small cells in the field, as revealed by 
DAPI staining of their nuclei (Fig. 6, c and f), showed little 
or no specific staining with anti-PCNA antibodies (Fig. 6, b 
and e). In contrast, all of the large cells in Fig. 6, a-c, stained 
relatively intensely. Careful comparison of phase-contrast 
Frc. 6. Immunolocalization of Drosophila PCNA in inter- 
phase and mitotic cells. Neural ganglia were prepared for indirect 
immunofluorescence and processed as described under “Experimental 
Procedures.” Specimens in a-f were probed with affinity-purified 
anti-Drocophiln PCNA IgG at a final concentration of 0.125 pg/ml; 
specimens in g-i were probed with preimmune IgG at a final concen- 
tration of 1 fig/ml. Phase-contrast (a, d, and g), immunofluorescence 
(b, e, and h), and DAPI fluorescence (c, f, and i) micrographs are 
shown. Arrows indicate mitot.ic cells. The bar in panel. h designates 
20 pm and applies to all panels. 
(Fig. 6a), immunofluorescence (Fig. 6b), and DAPI fluores- 
cence micrographs (Fig. 6~) revealed that in most of these 
large cells, PCNA was apparently distributed diffusely 
throughout the nucleus with the possible exception of the 
nucleolus. In Fig. 6, d-f, a mitotic cell is shown; it stained 
intensely throughout with anti-PCNA antibodies. All other 
cells in this field were negative. 
Polytene chromosomes are found in many different Dro- 
sophila cells and tissues. The process of polytenization is 
thought to involve ongoing DNA replication without separa- 
tion of daughter DNA molecules between successive rounds. 
This results in a polytene chromosome, easily visible at the 
light microscopic level, with as many as 1,000 copies of duplex 
DNA aligned linearly. The presence of PCNA in Drosophila 
polytene chromosomes was evaluated by indirect immunoflu- 
orescence microscopy using squash preparations of third in- 
star larval salivary gland giant cells. Results of this analysis 
are shown in Fig. 7. Fig. 7, a and c, are phase-contrast 
micrographs; Fig. 7, b and d, are immunofluorescence micro- 
graphs. The specimen in Fig. 7, a and b, was probed with 
affinity-purified anti-PCNA antibodies; the specimen in Fig. 
7, c and d, was probed with preimmune rabbit IgG. Clearly, 
there is specific staining of the polytene chromosomes along 
their entire lengths, with obvious heterogeneity in the pattern. 
This heterogeneity is of uncertain significance. 
DISCUSSION 
In this paper, we report the identification and purification 
of a PCNA homolog from D. melanogaster embryos. NH,- 
terminal amino acid sequence analysis as well as determina- 
tions of total amino acid composition indicate a high degree 
of conservation between Drosophila PCNA and mammalian 
PCNA; functional studies demonstrate that Drosophila PCNA 
can substitute for human PCNA in the reconstituted SV40 
DNA replication reaction. These observations, in conjunction 
with results of developmental and immunocytochemical anal- 
yses, suggest that in Drosophila, PCNA plays a role in DNA 
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and Macdonald-Bravo, 1987), PCNA is virtually undetectable 
by immunocytochemical techniques following methanol fixa- 
tion of cells, this despite the fact that immunoblot analyses 
demonstrate the continued presence of this protein (Wold et 
al., 1988; Morris and Matthews, 1989). In contrast, in fully 
differentiated nondividing tissues, PCNA is undetectable 
either by immunoblot or immunofluorescence analysis. 
FIG. 7. Polytene chromosome staining with anti-Drosoph- 
ila PCNA IgG. Salivary glands of third instar larvae were prepared 
and processed as described under “Experimental Procedures.” The 
specimen in a and b was probed with affinity-purified anti-l)rosophila 
PCNA I& at a final concentration of 0.1% &ml; the suecimen in c 
and d was probed with preimmune IgG at a final concentration of 1 
&ml. Phase-contrast (a and c) and immunofluorescence micro- 
graphs (b and d) are shown. The bar in panel d designates 20 pm and 
applies to all panels 
replication similar to that proposed for mammalian and yeast 
ceils. 
In mammals, PCNA acts as a processivity factor for DNA 
polymerase 6. To date, DNA polymerase 6 has not been 
identified in Drosophila. The identification of a Drosophila 
PCNA homolog suggests that a DNA polymerase b homolog 
exists as well. Results of nreliminarv exoeriments nerformed 
in one of our laboratoriesjndicate &at there is indeed a DNA 
polymerase activity in Drosophila embryo extracts which is 
stimulated by PCNA and can be distinguished from DNA 
polymerase N immunochemically.” 
Results of developmental immunoblot analyses in Drosoph- 
ila are consistent with observations made in mammalian cells. 
The decrease in absolute levels of PCNA during embryogen- 
esis, in contrast to the behavior of two other nuclear proteins, 
lamin and DNA topoisomerase II, suggests that as cells stop 
replicating and dividing during embryogenesis, new synthesis 
of PCNA slows (stops), and eventually the protein is lost. At 
later developmental stages, there is relatively little DNA 
synthesis that occurs, and this is reflected by the relative lack 
of PCNA. The most notable exception to this trend can be 
appreciated by comparing adult males with adult females. 
Although undetectable in the former, a band with the expected 
SDS-PAGE mobility of PCNA is seen in the latter. In light 
of the high levels of PCNA in early embryos, we think it likely 
that PCNA detectable in adult females is derived from the 
ovary where it is being stockpiled in the developing oocyte 
along with other proteins needed in large quantities early in 
embryogenesis (see e.g. Smith and Fisher, 1989). This sugges- 
tion will need to be evaluated by in situ immunocytochemistry. 
The postulated role of mammalian PCNA to promote the 
processivity of DNA polymerase 6 and to facilitate coordi- 
nated leading and lagging strand replication by DNA polym- 
erases 6 and a, respectively, suggests that PCNA interacts 
with DNA polymerase 6 as well as with other proteins in the 
replication fork. Recently, human PCNA was shown to inter- 
act with another replication factor, RF-C; RF-C stimulates 
both polymerases N and 6 (Tsurimoto and Stillman, 1989b, 
1990). That Drosophila PCNA can substitute for human 
PCNA in the reconstituted SV40 DNA replication system 
suggests that those PCNA domains important for interactions 
with both DNA polymerase 6 and RF-C are conserved between 
Drosophila and humans. In contrast, yeast PCNA can stimu- 
late mammalian DNA polymerase 6 (Bauer and Burgers, 1988) 
but cannot replace human PCNA during SV40 DNA replica- 
tion in uitro.’ Comparison of complete PCNA sequences from 
all three species once they are available may therefore yield 
important insights into the organization of functional do- 
The results of developmental immunoblot analyses were 
corroborated by those of indirect immunofluorescence exper- 
iments performed with affinity-purified anti-PCNA antibod- 
ies. In cryosections through third instar larvae where PCNA 
was virtually undetectable on immunoblots, little immunoflu- 
orescent staining was demonstrable overall.’ However, when 
selected third instar larval tissues known to contain cells 
active in DNA replication were examined, PCNA could be 
identified. In neural ganglion tissue, although we cannot be 
certain that those cells that were positive for PCNA were 
actually replicating their DNA, the number of cells in which 
staining was observed was roughly what might be predicted 
based on the mitotic index of the tissue. In this context, it is 
noteworthy that all mitotic cells examined stained intensely 
with anti-PCNA antibodies, in contrast to mammalian tissue 
culture in which mitotic cells stain very weakly compared 
with S phase cells. In salivary gland cells, staining of polytene 
chromosomes was readily demonstrable in all nuclei exam- 
ined, provided that young third instar larvae were used. Po- 
lytenization occurs through DNA replication. The presence 
of PCNA in polytene chromosomes suggests that both DNA 
polymerases N and 6 are involved. 
mains on the protein. 
In mammalian cells. the svnthesis of PCNA is Dartiallv 
regulated during the cell cycle, with the highest rates being 
observed in late G, and early S phase (see Bravo and Mac- 
donald-Bravo, 1985; Morris and Matthews, 1989). More strik- 
ing, however, are the changes in the immunofluorescent stain- 
ing pattern observed with anti-PCNA antibodies (Celis and 
Celis, 1985a; Bravo and Macdonald-Bravo, 1985, 1987). Dur- 
ing S phase, PCNA is readily detectable, and intranuclear 
distribution of PCNA changes both qualitatively and quanti- 
tatively as DNA replication progresses. During other phases 
of the cell cycle, with the possible exception of mitosis (Bravo 
In conclusion, the identification of PCNA in Drosophila, 
the availability of polyclonal anti-PCNA antibodies, and the 
fact that these antibodies are apparently useful probes for the 
presence of PCNA both on immunoblots and in situ should 
facilitate detailed analysis of this protein and patterns of cell 
division during differentiation and development. Results of 
such studies are likely to provide novel insights into the role 
of cell proliferation in regulating these processes. 
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